Standout Papers
Citation Impact
Citing Papers
Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients
2007
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Head and neck squamous cell carcinoma
2020 Standout
Pretreatment Identification of Head and Neck Cancer Nodal Metastasis and Extranodal Extension Using Deep Learning Neural Networks
2018
Nasopharyngeal carcinoma
2005 Standout
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma
2003
Thyroid cancer
2016 Standout
Radiation‐induced xerostomia in patients with head and neck cancer
2006
High-dose, high-precision treatment options for boosting cancer of the nasopharynx
2002
Matched case–control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report
2005
Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma
2003
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
2015
Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins
2006
Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets
2002
Individualized treatment in stage IVC nasopharyngeal carcinoma
2014
Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma
2010
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome
2008 Standout
Partial irradiation of the parotid gland
2001
Intensity‐modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma
2006
Treatment of Nasopharyngeal Carcinoma Using Intensity-Modulated Radiotherapy—The National Cancer Centre Singapore Experience
2009
Head and neck cancer
2008 Standout
AI in health and medicine
2022 Standout
Nasopharyngeal carcinoma
2019 Standout
A systematic review of trismus induced by cancer therapies in head and neck cancer patients
2010
Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy
2010
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials
2001
Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy
2002
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
2013
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
2012
Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma
2003
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond
2005
Conformity index: A review
2006 Standout
Oral complications of cancer and cancer therapy
2012
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma
2008
Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma
2002
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
2016
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Preservation of oral health–related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer
2004
Preparing Medical Imaging Data for Machine Learning
2020 Standout
Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs
2017
Unnecessary laryngeal irradiation in the IMRT era
2004
Privacy in the age of medical big data
2018 Standout
Lung metastasis alone in nasopharyngeal carcinoma: A relatively favorable prognostic group
2004
Clinical use of intensity-modulated radiotherapy: part II
2004
Nasopharyngeal carcinoma
2015 Standout
Deep Learning for Automated Contouring of Primary Tumor Volumes by MRI for Nasopharyngeal Carcinoma
2019
Induction Chemotherapy with Nedaplatin with 5-FU Followed by Intensity-modulated Radiotherapy Concurrent with Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
2010
Cancers des voies aérodigestives supérieures : bénéfices cliniques de la radiothérapie conformationnelle et de la modulation d’intensité
2002
Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation
2003
Malignant Gliomas in Adults
2008 Standout
Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy
2014
Efficacy of targeted FasL in nasopharyngeal carcinoma
2003
Correlation Between Saliva Production and Quality of Life Measurements in Head and Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy
2007
Epstein–Barr virus: 40 years on
2004 Standout
Preservation of quality of life after intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma: Results of a prospective longitudinal study
2006
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
2018
The battle against nasopharyngeal cancer
2012
Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
2004
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
Primary brain tumours in adults
2012 Standout
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial
2006
New Radiation Therapy Techniques for the Treatment of Head and Neck Cancer
2005
Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy
2004
Concurrent Chemo-Radiation With or Without Induction Gemcitabine, Carboplatin, and Paclitaxel: A Randomized, Phase 2/3 Trial in Locally Advanced Nasopharyngeal Carcinoma
2015
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
2000
Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
2013 Standout
Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage
2002
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
2011 Standout
Clinical use of intensity-modulated radiotherapy: part I
2004
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Intensity‐modulated radiotherapy for early‐stage nasopharyngeal carcinoma
2004
Quality of Life and Survival Outcome for Patients With Nasopharyngeal Carcinoma Receiving Three-Dimensional Conformal Radiotherapy vs. Intensity-Modulated Radiotherapy—A Longitudinal Study
2008
Salvage gemcitabine–vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy
2012
Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis
2015
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial
2016
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
2013
Anaplastic thyroid cancer
2013
A Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade Gliomas: The Impact of the Extent of Resection on Quality of Life and Survival
2005
Proposed modifications and incorporation of plasma Epstein‐Barr virus DNA improve the TNM staging system for Epstein‐Barr virus‐related nasopharyngeal carcinoma
2018
Evidence on effectiveness of intensity‐modulated radiotherapy versus 2‐dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta‐analysis and a systematic review of the literature
2014
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial
2006
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
2009
Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.
2013
La radiothérapie conformationnelle est-elle un progrès? Quelles en sont les difficultés et les limites?
2001
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
2006
Morbidities after maxillary swing nasopharyngectomy for recurrent nasopharyngeal carcinoma
2014
Guidelines for the management of thyroid cancer
2014 Standout
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma
2013
Long‐term outcomes after reirradiation in nasopharyngeal carcinoma with intensity‐modulated radiotherapy: A meta‐analysis
2017
Works of Khalil Sultanem being referenced
Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer
2004
Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer
2017
Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California–San Francisco experience
2000
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia
2008
The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial
2003
Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)
2016
12 3-D intensity modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma: The UCSF experience
1999